Literature DB >> 35645798

Mannose: A Sweet Option in the Treatment of Cancer and Inflammation.

Fang Nan1, Yutong Sun1, Hantian Liang1, Jingyang Zhou1, Xiao Ma1, Dunfang Zhang1.   

Abstract

As a natural sugar, mannose is a type of hexose that is abundant in many different types of fruits. Since mannose is rarely used for glycolysis in mammals, studies on the role of mannose have not attracted much attention. Glycosylation of specific proteins was thought to be the major function of mannose. Surprisingly, during the past few years, mannose was found to be effective in promoting immune tolerance and suppressing inflammatory diseases related to autoimmunity and allergy. Moreover importantly, mannose was also found to be efficient in suppressing tumors by suppressing glycolysis and enhancing chemotherapeutic agents. In this review, we summarize the recent studies of mannose on antitumor properties and anti-inflammatory characteristics. We emphasize that mannose could play a beneficial role in the treatment of a variety of diseases, including cancers and inflammatory diseases, and could be a novel therapeutic strategy that deserves continued evaluation.
Copyright © 2022 Nan, Sun, Liang, Zhou, Ma and Zhang.

Entities:  

Keywords:  autoimmune disorders; glycolysis; mannose; mannose phosphate isomerase; treg cells; tumor therapy

Year:  2022        PMID: 35645798      PMCID: PMC9136145          DOI: 10.3389/fphar.2022.877543

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.988


  46 in total

Review 1.  Dendritic cells in cancer immunology and immunotherapy.

Authors:  Stefanie K Wculek; Francisco J Cueto; Adriana M Mujal; Ignacio Melero; Matthew F Krummel; David Sancho
Journal:  Nat Rev Immunol       Date:  2019-08-29       Impact factor: 53.106

Review 2.  What is new in CDG?

Authors:  Jaak Jaeken; Romain Péanne
Journal:  J Inherit Metab Dis       Date:  2017-05-08       Impact factor: 4.982

Review 3.  Mannose: Good player and assister in pharmacotherapy.

Authors:  Zewei Wei; Lianfang Huang; Liao Cui; Xiao Zhu
Journal:  Biomed Pharmacother       Date:  2020-06-18       Impact factor: 6.529

4.  Effect of D-mannose on Philadelphia chromosome-positive leukemia cells.

Authors:  Seiichi Okabe; Yuko Tanaka; Akihiko Gotoh
Journal:  Cancer Biomark       Date:  2022       Impact factor: 4.388

Review 5.  Glucose transporters in the 21st Century.

Authors:  Bernard Thorens; Mike Mueckler
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

6.  Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function.

Authors:  Carol A de la Motte; Vincent C Hascall; Judith Drazba; Sudip K Bandyopadhyay; Scott A Strong
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

7.  Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans.

Authors:  Charles DeRossi; Kathryn Bambino; Joshua Morrison; Isabel Sakarin; Carlos Villacorta-Martin; Changwen Zhang; Jillian L Ellis; M Isabel Fiel; Maria Ybanez; Youngmin A Lee; Kuan-Lin Huang; Chunyue Yin; Takuya F Sakaguchi; Scott L Friedman; Augusto Villanueva; Jaime Chu
Journal:  Hepatology       Date:  2019-05-24       Impact factor: 17.425

Review 8.  The Warburg effect and drug resistance.

Authors:  Bhaskar Bhattacharya; Mohd Feroz Mohd Omar; Richie Soong
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

Review 9.  Dietary Approaches to Cancer Therapy.

Authors:  Mylène Tajan; Karen H Vousden
Journal:  Cancer Cell       Date:  2020-05-14       Impact factor: 38.585

10.  Mannose Impairs Lung Adenocarcinoma Growth and Enhances the Sensitivity of A549 Cells to Carboplatin.

Authors:  Jun Sha; Dandan Cao; Rui Cui; Lu Xia; Xin Hua; Yuan Lu; Shuhua Han
Journal:  Cancer Manag Res       Date:  2020-11-03       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.